Intraneuronal β-amyloid impaired mitochondrial proteostasis through the impact on LONP1
Proceedings of the National Academy of Sciences · 2023
DOI: 10.1073/pnas.2316823120 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2023. Verfasst von Wenzhang Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Case Western Reserve University, Cleveland, OH 44106. Hauptthemen laut MEDLINE: Alzheimer Disease, Mitochondrial Diseases. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIA NIH HHS, NCATS NIH HHS, NINDS NIH HHS.
Abstract (Originalsprache)
Mitochondrial dysfunction plays a critical role in the pathogenesis of Alzheimer’s disease (AD). Mitochondrial proteostasis regulated by chaperones and proteases in each compartment of mitochondria is critical for mitochondrial function, and it is suspected that mitochondrial proteostasis deficits may be involved in mitochondrial dysfunction in AD. In this study, we identified LONP1, an ATP-dependent protease in the matrix, as a top Aβ42 interacting mitochondrial protein through an unbiased screening and found significantly decreased LONP1 expression and extensive mitochondrial proteostasis deficits in AD experimental models both in vitro and in vivo, as well as in the brain of AD patients. Impaired METTL3-m 6 A signaling contributed at least in part to Aβ42-induced LONP1 reduction. Moreover, Aβ42 interaction with LONP1 impaired the assembly and protease activity of LONP1 both in vitro and in vivo. Importantly, LONP1 knockdown caused mitochondrial proteostasis deficits and dysfunction in neurons, while restored expression of LONP1 in neurons expressing intracellular Aβ and in the brain of CRND8 APP transgenic mice rescued Aβ-induced mitochondrial deficits and cognitive deficits. These results demonstrated a critical role of LONP1 in disturbed mitochondrial proteostasis and mitochondrial dysfunction in AD and revealed a mechanism underlying intracellular Aβ42-induced mitochondrial toxicity through its impact on LONP1 and mitochondrial proteostasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Case Western Reserve University, Cleveland, OH 44106.
- Electron Microscopy Core Facility, Case Western Reserve University, Cleveland, OH 44106.
ORCID-Profile: Wenzhang Wang, Hisashi Fujioka, Sandy Torres, Xiongwei Zhu
Förderung
- NIA NIH HHS
- NCATS NIH HHS
- NINDS NIH HHS
- HHS | National Institutes of Health
- Alzheimer's Association
Zitieren
APA
Wang, W., Ma, X., Bhatta, S., Shao, C., Zhao, F., Fujioka, H., Torres, S., Wu, F., & Zhu, X. (2023). Intraneuronal β-amyloid impaired mitochondrial proteostasis through the impact on LONP1. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2316823120
Vancouver
Wang W, Ma X, Bhatta S, Shao C, Zhao F, Fujioka H, et al. Intraneuronal β-amyloid impaired mitochondrial proteostasis through the impact on LONP1. Proceedings of the National Academy of Sciences. 2023. doi:10.1073/pnas.2316823120
BibTeX
@article{Wang2023,
author = {Wang, Wenzhang and Ma, Xiaopin and Bhatta, Sabina and Shao, Changjuan and Zhao, Fanpeng and Fujioka, Hisashi and Torres, Sandy and Wu, Fengqin and Zhu, Xiongwei},
title = {Intraneuronal β-amyloid impaired mitochondrial proteostasis through the impact on LONP1},
journal = {Proceedings of the National Academy of Sciences},
year = {2023},
doi = {10.1073/pnas.2316823120}
}
EUVIMED